Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers

Occurrence and Management of Immunotherapy-Associated Adverse Events in Patients with Gynecological Cancers

Background: Immune checkpoint inhibitors (ICIs) have emerged as an essential therapeutic approach in treating many solid tumors. ICIs enhance the body’s anti-tumor T-cell activity, resulting in a novel spectrum of immunotherapy-related side effects. This novel spectrum of adverse events differs sign...

Full description

Bibliographic Details
Main Authors: Ina Shehaj, Maria Schröder, Valerie Catherine Linz, Slavomir Krajnak, Katrin Almstedt, Kathrin Stewen, Roxana Schwab, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heimes
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
immunotherapy-related adverse events
immune checkpoint inhibitors
gynecological malignancies
Online Access:https://www.mdpi.com/2072-6694/16/7/1371

Internet

https://www.mdpi.com/2072-6694/16/7/1371

Similar Items